Evaluate effects of acellular equine liquid amnion allograft (ELAA) injected into healthy equine joints. Randomized, blinded, controlled experiment. Eight healthy adult horses. One intercarpal joint (ICJ) of each horse was randomly assigned to be injected with 1.5ml of ELAA (treatment) while the contralateral ICJ was injected with 1.5ml of 0.9% NaCl (control). Subjective lameness evaluation, force plate analysis, and synovial fluid analysis, including interleukin-1 receptor antagonist (IL-1ra) analysis, were performed before (day 0) and at days 1, 3, 5, and 10. Synovial fluid analysis was also performed on days 20 and 30. No difference in subjective lameness (P=.75) and no decrease in peak vertical force or vertical impulse were seen in any limb on any day. Total nucleated cell count (TNCC) was increased in treatment joints on days 1 (P=.0007; T: 6039 cells/μl, C: 240 cells/μl) and 3 (P < .0001; T: 1119 cells/μl, C: 240 cells/μl). Log-10 transformed values for IL-1ra were higher in treated joints on days 1 (P=.0005; T: 3553.7pg/ml, C: 1890.1pg/ml) and 3 (P=.01; T: 2283.2pg/ml, C: 1250.7pg/ml). Injection of ELAA into the ICJ caused an increase in synovial fluid TNCC in comparison with saline control but no lameness was observed. There was increased IL-1ra on days 1 and 3 after ELAA injection. Intra-articular injection of ELAA into healthy equine joints results in no significant safety concerns. The observed increase in IL-1ra may provide beneficial effects in inflamed joints.